{"id":57625,"date":"2024-10-17T06:33:55","date_gmt":"2024-10-16T19:33:55","guid":{"rendered":"https:\/\/www.tomgrimshaw.com\/tomsblog\/maintenance.html\/?p=57625"},"modified":"2024-10-17T06:33:55","modified_gmt":"2024-10-16T19:33:55","slug":"mrna-covid-jab-ingredient-n1-methyl-pseudouridine-m1%cf%88-stimulated-cancer-growth-and-metastasis","status":"publish","type":"post","link":"https:\/\/www.tomgrimshaw.com\/tomsblog\/?p=57625","title":{"rendered":"mRNA COVID Jab Ingredient N1-Methyl-Pseudouridine (m1\u03a8) &#8216;Stimulated Cancer Growth and Metastasis&#8217;"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-57626\" src=\"https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2024\/10\/N1-methyl-pseudouridine.jpg\" alt=\"N1-methyl-pseudouridine\" width=\"1300\" height=\"650\" srcset=\"https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2024\/10\/N1-methyl-pseudouridine.jpg 1300w, https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2024\/10\/N1-methyl-pseudouridine-300x150.jpg 300w, https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2024\/10\/N1-methyl-pseudouridine-1024x512.jpg 1024w, https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2024\/10\/N1-methyl-pseudouridine-768x384.jpg 768w\" sizes=\"auto, (max-width: 767px) 89vw, (max-width: 1000px) 54vw, (max-width: 1071px) 543px, 580px\" \/><br \/>\nA new\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38583833\/\" rel=\"\">study<\/a>\u00a0published earlier this month in the\u00a0<em><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0141813024022323\" rel=\"\">International Journal of Biological Macromolecules<\/a><\/em>\u00a0confirms that an ingredient in mRNA COVID-19 injections called N1-methyl-pseudouridine (m1\u03a8) increases cancer growth and spread.<\/p>\n<p>m1\u03a8 is a component of the Pfizer Inc. and Moderna Inc. mRNA jabs.<\/p>\n<p>The new study provides evidence \u201cthat adding 100 % of N1-methyl-pseudouridine (m1\u03a8) to the mRNA vaccine in a melanoma model stimulated cancer growth and metastasis, while non-modified mRNA vaccines induced opposite results, thus suggesting that COVID-19 mRNA vaccines could aid cancer development.\u201d<\/p>\n<p>The authors point out how during the massive COVID vaccination campaigns, it was \u201cfrequently stated [that] the benefits [of taking the jab] outweigh the risks.\u201d<\/p>\n<p>\u201cHowever, after the third dose, the risk exceeds the benefits, especially for the elderly and immunocompromised individuals, so health authorities should re-evaluate the real usefulness of continuing to administer boosters,\u201d they argue.<\/p>\n<p>The authors critique the jab further, explaining that there is increasing evidence that mRNA vaccines do not provide complete immunity, which could lead to repeated infections, and that the shots can disrupt crucial immune processes.<\/p>\n<p>\u201cMounting evidence indicates that these vaccines, like many others, do not generate sterilizing immunity, leaving people vulnerable to recurrent infections,\u201d they write. \u201cAdditionally, it has been discovered that the mRNA vaccines inhibit essential immunological pathways, thus impairing early interferon signaling.\u201d<\/p>\n<p>The evidence drove the authors to recommend future clinical trials that use mRNA vaccines with less m1\u03a8 in order to avoid weakening the immune system.<\/p>\n<p>\u201cBased on this compelling evidence, we suggest that future clinical trials for cancers or infectious diseases should not use mRNA vaccines with a 100 % m1\u03a8 modification, but rather ones with the lower percentage of m1\u03a8 modification to avoid immune suppression,\u201d they conclude.<\/p>\n<p>Meanwhile, another peer-reviewed study published this month in\u00a0<em>Cureus<\/em>\u00a0<a href=\"https:\/\/jonfleetwood.substack.com\/p\/excess-cancer-deaths-spike-from-1379?utm_source=publication-search\" rel=\"\">found<\/a>\u00a0significant increases in mortality rates of all cancer types in 2022 after the majority of the Japanese population received doses of the COVID mRNA shot.<\/p>\n<p>\u201cStatistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip\/oral\/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARS-CoV-2 mRNA-LNP vaccine,\u201d the study reads.<\/p>\n<p>(Tom: Just did several unsuccessful internet searches looking for what would remove, deactivate or otherwise mitigate the bodily harm from N1-methyl-pseudouridine.)<\/p>\n<p><a href=\"https:\/\/jonfleetwood.substack.com\/p\/mrna-covid-jab-ingredient-n1-methyl\">https:\/\/jonfleetwood.substack.com\/p\/mrna-covid-jab-ingredient-n1-methyl<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new\u00a0study\u00a0published earlier this month in the\u00a0International Journal of Biological Macromolecules\u00a0confirms that an ingredient in mRNA COVID-19 injections called N1-methyl-pseudouridine (m1\u03a8) increases cancer growth and spread. m1\u03a8 is a component of the Pfizer Inc. and Moderna Inc. mRNA jabs. The new study provides evidence \u201cthat adding 100 % of N1-methyl-pseudouridine (m1\u03a8) to the mRNA vaccine &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.tomgrimshaw.com\/tomsblog\/?p=57625\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;mRNA COVID Jab Ingredient N1-Methyl-Pseudouridine (m1\u03a8) &#8216;Stimulated Cancer Growth and Metastasis&#8217;&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5,6,133],"tags":[],"class_list":["post-57625","post","type-post","status-publish","format-standard","hentry","category-general-interest","category-health-tips","category-vaccines"],"_links":{"self":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts\/57625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=57625"}],"version-history":[{"count":1,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts\/57625\/revisions"}],"predecessor-version":[{"id":57627,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts\/57625\/revisions\/57627"}],"wp:attachment":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=57625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=57625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=57625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}